Ferroptosis: Mechanism and potential applications in cervical cancer

被引:18
作者
Chang, Xiangyu [1 ]
Miao, Jinwei [1 ]
机构
[1] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Gynecol Oncol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
cervical cancer; ferroptosis; lipid peroxidation; iron accumulation; treatment; GLUTATHIONE-PEROXIDASE; 4; CELL-DEATH; HUMAN-PAPILLOMAVIRUS; CISPLATIN RESISTANCE; IRON; PROTECTS; METABOLISM; BIOMARKER; STRESS; ROLES;
D O I
10.3389/fmolb.2023.1164398
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ferroptosis is a distinct form of cell death mechanism different from the traditional ones. Ferroptosis is characterized biochemically by lipid peroxidation, iron accumulation, and glutathione deficiency. It has already demonstrated significant promise in antitumor therapy. Cervical cancer (CC) progression is closely linked to iron regulation and oxidative stress. Existing research has investigated the role of ferroptosis in CC. Ferroptosis could open up a new avenue of research for treating CC. This review will describe the factors and pathways and the research basis of ferroptosis, which is closely related to CC. Furthermore, the review may provide potential future directions for CC research, and we believe that more studies concerning the therapeutic implications of ferroptosis in CC will come to notice.
引用
收藏
页数:8
相关论文
共 80 条
[1]   NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis [J].
Alvarez, Samantha W. ;
Sviderskiy, Vladislav O. ;
Terzi, Erdem M. ;
Papagiannakopoulos, Thales ;
Moreira, Andre L. ;
Adams, Sylvia ;
Sabatini, David M. ;
Birsoy, Kivanc ;
Possemato, Richard .
NATURE, 2017, 551 (7682) :639-+
[2]   Cisplatin resistance and opportunities for precision medicine [J].
Amable, Lauren .
PHARMACOLOGICAL RESEARCH, 2016, 106 :27-36
[3]   Regulation of autophagy by high- and low-risk human papillomaviruses [J].
Aranda-Rivera, Ana Karina ;
Cruz-Gregorio, Alfredo ;
Briones-Herrera, Alfredo ;
Pedraza-Chaverri, Jose .
REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (02)
[4]   Targeting DNA Damage Response as a Strategy to Treat HPV Infections [J].
Banerjee, N. Sanjib ;
Moore, Dianne ;
Parker, Cameron J. ;
Broker, Thomas R. ;
Chow, Louise T. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
[5]   Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis [J].
Braun, Julia A. ;
Herrmann, Anja L. ;
Blase, Johanna, I ;
Frensemeier, Kristin ;
Bulkescher, Julia ;
Scheffner, Martin ;
Galy, Bruno ;
Hoppe-Seyler, Karin ;
Hoppe-Seyler, Felix .
INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (02) :461-474
[6]   System xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS [J].
Bridges, Richard J. ;
Natale, Nicholas R. ;
Patel, Sarjubhai A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (01) :20-34
[7]   Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export [J].
Brown, Caitlin W. ;
Amante, John J. ;
Chhoy, Peter ;
Elaimy, Ameer L. ;
Liu, Haibo ;
Zhu, Lihua Julie ;
Baer, Christina E. ;
Dixon, Scott J. ;
Mercurio, Arthur M. .
DEVELOPMENTAL CELL, 2019, 51 (05) :575-+
[8]   Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors [J].
Canli, Oezge ;
Alankus, Yasemin B. ;
Grootjans, Sasker ;
Vegi, Naidu ;
Hueltner, Lothar ;
Hoppe, Philipp S. ;
Schroeder, Timm ;
Vandenabeele, Peter ;
Bornkamm, Georg W. ;
Greten, Florian R. .
BLOOD, 2016, 127 (01) :139-148
[9]   Association between serum iron levels and the risk of cervical cancer in Chinese: a meta-analysis [J].
Chen, Shu ;
Shen, Liyuan ;
Luo, Shujuan ;
Lan, Xia ;
Wang, Lan .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019,
[10]   Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo [J].
Chen, Szu-Jung ;
Kuo, Ching-Chuan ;
Pan, Hsin-Yi ;
Tsou, Tsui-Chun ;
Yeh, Szu-Ching ;
Chang, Jang-Yang .
ONCOTARGET, 2016, 7 (31) :49310-49321